Td Capital Management Has Lowered Its Autozone (AZO) Holding by $1.44 Million; Shares Rose; Loxo Oncology (LOXO) Holder Ameriprise Financial Has Boosted Its Position by $11.26 Million

Loxo Oncology, Inc. (NASDAQ:LOXO) Logo

Ameriprise Financial Inc increased its stake in Loxo Oncology Inc (LOXO) by 35.97% based on its latest 2018Q4 regulatory filing with the SEC. Ameriprise Financial Inc bought 80,439 shares as the company’s stock 0.00% . The institutional investor held 304,086 shares of the health care company at the end of 2018Q4, valued at $42.59M, up from 223,647 at the end of the previous reported quarter. Ameriprise Financial Inc who had been investing in Loxo Oncology Inc for a number of months, seems to be bullish on the $7.22 billion market cap company. It closed at $234.66 lastly. It is down 0.00% since April 18, 2018 and is . It has underperformed by 4.37% the S&P500. Some Historical LOXO News: 29/05/2018 – LOXO ONCOLOGY INC – LAROTRECTINIB HAS ALSO BEEN GRANTED BREAKTHROUGH THERAPY DESIGNATION; 10/04/2018 – ILLUMINA INC – LOXO ONCOLOGY TO UTILIZE A COMPANION DIAGNOSTIC VERSION OF TRUSIGHT TUMOR 170 FOR LAROTRECTINIB (NTRK) AND LOXO-292 (RET); 10/04/2018 – Illumina and Loxo Oncology to Partner on Developing Next-Generation Sequencing-Based Pan-Cancer Companion Diagnostics; 11/04/2018 – VERACYTE REPORTS PRECISION MEDICINE PACT WITH LOXO ONCOLOGY; 04/04/2018 – Loxo Oncology Announces Acceptance of LOXO-292 Oral Presentation at the Amer Society of Clinical Oncology (ASCO) Annual Meeting; 17/05/2018 – #2 — UPDATED: The top winners and losers on ASCO abstract night: Loxo, Blueprint, Jounce, Merck KGaA and more; 10/04/2018 – LOXO ONCOLOGY – COMPANIES ALSO PLANNING TO BROADEN CLINICAL UTILITY OF FULL PANEL BY OBTAINING REGULATORY APPROVAL FOR OTHER ASSAY CONTENT; 04/04/2018 – Loxo Oncology Announces Acceptance of LOXO-292 Oral Presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting; 16/05/2018 – LOXO-292 OVERALL RESPONSE RATE 69 PERCENT IN LUNG AND PAPILLARY THYROID TUMORS – PRELIMINARY DATA; 15/04/2018 – $BPMC some pretty amazing scans for BLU-667 in RET-driven cancers in newly published Cancer Discovery paper

Td Capital Management Llc decreased its stake in Autozone Inc (AZO) by 6.7% based on its latest 2018Q4 regulatory filing with the SEC. Td Capital Management Llc sold 1,722 shares as the company’s stock rose 11.90% with the market. The institutional investor held 23,975 shares of the consumer services company at the end of 2018Q4, valued at $20.10M, down from 25,697 at the end of the previous reported quarter. Td Capital Management Llc who had been investing in Autozone Inc for a number of months, seems to be less bullish one the $26.02 billion market cap company. The stock decreased 0.56% or $5.93 during the last trading session, reaching $1045.44. About 161,209 shares traded. AutoZone, Inc. (NYSE:AZO) has risen 40.93% since April 18, 2018 and is uptrending. It has outperformed by 36.56% the S&P500. Some Historical AZO News: 20/03/2018 – AutoZone Authorizes Additional Stk Repurchase; 15/05/2018 – AutoZone Appoints New Board Members; 15/05/2018 – AUTOZONE INC – WITH ADDITIONS OF KING AND SOLTAU, AUTOZONE NOW HAS 12 BOARD MEMBERS; 03/05/2018 – CAM Group Adds Becton Dickinson, Exits AutoZone: 13F; 22/05/2018 – AUTOZONE INC – QTR-END INVENTORY INCREASED 3.7% OVER SAME PERIOD LAST YEAR; 15/05/2018 – AUTOZONE INC – ANNOUNCED APPOINTMENT OF GALE V. KING AND JILL SOLTAU TO AUTOZONE BOARD OF DIRECTORS; 22/05/2018 – AUTOZONE INC – DOMESTIC SAME STORE SALES, OR SALES FOR STORES OPEN AT LEAST ONE YEAR, INCREASED 0.6% FOR QUARTER; 01/05/2018 – AutoZone to Attend Upcoming International Council of Shopping Centers’ 2018 RECon – The Global Real Estate Convention; 31/03/2018 – Cal EMA Spills: SPILL Report – Auto Zone – 03/31/2018 10:54 AM; 26/04/2018 – AutoZone to Release Third Quarter Earnings May 22, 2018

Ameriprise Financial Inc, which manages about $199.95B US Long portfolio, decreased its stake in Ishares Core Msci Eafe Etf (IEFA) by 118,844 shares to 7.45M shares, valued at $409.57 million in 2018Q4, according to the filing. It also reduced its holding in First Trust Rising Dividend (RDVY) by 198,179 shares in the quarter, leaving it with 293,752 shares, and cut its stake in Arrowhead Pharmaceut.

Investors sentiment decreased to 0.93 in Q4 2018. Its down 0.56, from 1.49 in 2018Q3. It turned negative, as 25 investors sold LOXO shares while 74 reduced holdings. 33 funds opened positions while 59 raised stakes. 28.12 million shares or 0.59% less from 28.29 million shares in 2018Q3 were reported. 1832 Asset Mngmt LP holds 0% or 8,500 shares in its portfolio. New York-based Sg Americas Securities Limited Liability has invested 0.01% in Loxo Oncology, Inc. (NASDAQ:LOXO). Dekabank Deutsche Girozentrale holds 11,380 shares. The Georgia-based Synovus has invested 0% in Loxo Oncology, Inc. (NASDAQ:LOXO). Morgan Stanley holds 0% or 74,524 shares. Marshall Wace Limited Liability Partnership reported 30,263 shares or 0.04% of all its holdings. Awm Inv Incorporated holds 70,000 shares or 2.13% of its portfolio. New York-based Tiaa Cref Inv Llc has invested 0.01% in Loxo Oncology, Inc. (NASDAQ:LOXO). Next Fincl Group Incorporated holds 0% in Loxo Oncology, Inc. (NASDAQ:LOXO) or 90 shares. Alliancebernstein Lp has 0.05% invested in Loxo Oncology, Inc. (NASDAQ:LOXO). Venbio Select Advisor Limited Liability Corporation reported 325,000 shares or 2.72% of all its holdings. Public Employees Retirement Association Of Colorado accumulated 2,189 shares. Driehaus Cap Mgmt Lc has invested 1.52% of its portfolio in Loxo Oncology, Inc. (NASDAQ:LOXO). Pitcairn Com holds 1,835 shares or 0.03% of its portfolio. Telemus Limited Liability Corp stated it has 0.05% of its portfolio in Loxo Oncology, Inc. (NASDAQ:LOXO).

Since November 26, 2018, it had 1 insider buy, and 4 selling transactions for $7.11 million activity. $2.71 million worth of Loxo Oncology, Inc. (NASDAQ:LOXO) was sold by Bilenker Joshua H.. Burstein Jennifer also sold $338,875 worth of Loxo Oncology, Inc. (NASDAQ:LOXO) on Monday, December 10. Shares for $1.22M were sold by Van Naarden Jacob.

More notable recent Loxo Oncology, Inc. (NASDAQ:LOXO) news were published by: Seekingalpha.com which released: “Loxo Oncology promotes from within for COO position – Seeking Alpha” on January 03, 2019, also Nasdaq.com with their article: “The Zacks Analyst Blog Highlights: Roche, Celgene, Johnson and Johnson, Bayer and Sunesis Pharmaceuticals – Nasdaq” published on March 28, 2019, Nasdaq.com published: “The 3 Best-Performing Biotech Stocks at the J.P. Morgan Healthcare Conference – Nasdaq” on January 11, 2019. More interesting news about Loxo Oncology, Inc. (NASDAQ:LOXO) were released by: Nasdaq.com and their article: “Pharma Stock Roundup: Lilly to Buy Loxo for $8B, M&A in Focus at JP Morgan Meet – Nasdaq” published on January 11, 2019 as well as Nasdaq.com‘s news article titled: “5 Cancer-Fighting Stocks to Boost Portfolio Gains – Nasdaq” with publication date: March 27, 2019.

Td Capital Management Llc, which manages about $485.45M and $405.69M US Long portfolio, upped its stake in Ishares Tr (IXUS) by 100,722 shares to 619,313 shares, valued at $32.53M in 2018Q4, according to the filing. It also increased its holding in Pimco Etf Tr (MINT) by 66,237 shares in the quarter, for a total of 531,517 shares, and has risen its stake in Vanguard Star Fd (VXUS).

Investors sentiment increased to 0.98 in 2018 Q4. Its up 0.15, from 0.83 in 2018Q3. It is positive, as 38 investors sold AZO shares while 193 reduced holdings. 93 funds opened positions while 133 raised stakes. 26.57 million shares or 17.59% more from 22.60 million shares in 2018Q3 were reported. Nfc Ltd Co holds 5.66% of its portfolio in AutoZone, Inc. (NYSE:AZO) for 20,676 shares. Comml Bank Of Montreal Can accumulated 0.12% or 149,444 shares. Invesco Ltd stated it has 0.13% in AutoZone, Inc. (NYSE:AZO). Sumitomo Mitsui Asset Ltd holds 0.03% of its portfolio in AutoZone, Inc. (NYSE:AZO) for 1,900 shares. Tower Research Lc (Trc) invested in 655 shares. Aperio Grp Incorporated Limited reported 27,570 shares. Brown Advisory Inc invested in 0.03% or 9,654 shares. Marshfield Associate has 7.27% invested in AutoZone, Inc. (NYSE:AZO) for 119,850 shares. Royal Natl Bank Of Canada has 0.01% invested in AutoZone, Inc. (NYSE:AZO) for 22,188 shares. Vanguard stated it has 2.30M shares. Pinnacle Fin Partners owns 0.06% invested in AutoZone, Inc. (NYSE:AZO) for 709 shares. World Asset Mngmt has 1,680 shares. Fund holds 0.01% of its portfolio in AutoZone, Inc. (NYSE:AZO) for 898 shares. Element Lc reported 1.94% in AutoZone, Inc. (NYSE:AZO). Landscape Capital Management Lc holds 3,493 shares or 0.24% of its portfolio.

Since October 30, 2018, it had 0 insider buys, and 10 selling transactions for $56.77 million activity. GRIFFIN RONALD B sold $17.74M worth of stock. Smith Richard Craig sold $1.26 million worth of stock or 1,500 shares. On Thursday, December 6 the insider GILES WILLIAM T sold $11.75M. Hackney William R. also sold $4.96M worth of AutoZone, Inc. (NYSE:AZO) on Friday, December 7. $10.27M worth of AutoZone, Inc. (NYSE:AZO) shares were sold by Finestone Mark A.. Shares for $1.33M were sold by Wright Kristen C. on Friday, December 14.

Loxo Oncology, Inc. (NASDAQ:LOXO) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.